Company Overview: Lion One Metals Limited (TSXV: LIO) is a mineral exploration and development company with a strategic focus on gold resources in Fiji. The company’s flagship asset is the Tuvatu Gold Project, located on the island of Viti Levu. Nektar Therapeutics (NASDAQ: NKTR) is a clinical-stage biotechnology company dedicated to developing innovative therapies for autoimmune, chronic inflammatory, and oncology-related diseases. The Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks. 

Global Markets Wrap-Up

As of May 29, 2025, major U.S. equity indices delivered strong week-to-date (WTD) performances, supported by broad sector gains. While the S&P 500 dipped slightly by 0.16% to close at 5,912.17, the NASDAQ Composite advanced 2.34%, ending the week at 19,175.87, buoyed by ongoing strength in the technology sector. The Russell 2000, a key gauge of small-cap equities, also posted solid gains, rising 1.71% to settle at 2,074.78.

As of May 29, the S&P/TSX Venture Composite Index (TSX: ^JX) posted a week-to-date (WTD) gain of 1.49%, closing at 696.88, maintaining its broader upward trajectory. While Thursday’s session reflected a generally negative market tone, strength in the technology sector provided near-term support, helping to sustain the index’s overall positive momentum. However, this was partially offset by persistent weakness across multiple key sectors, including consumer non-cyclicals, industrials, energy, healthcare, financials, consumer cyclicals, real estate, and basic materials. The underperformance in these areas tempered broader market gains and highlighted continued investor caution despite the index’s recent upward trend.